期刊文献+

拓宽视野,开创妇科内分泌研究新局面 被引量:2

原文传递
导出
摘要 近30年来,随着生物医学的不断发展与创新和辅助生殖技术(ART)的革命性突破,妇科内分泌学取得了有目共睹的进步。随着对妇科内分泌系统疾病的深入研究,妇科内分泌对女性长期健康产生深远影响的认识更加深入;逐步深入的基础研究使我们从遗传、免疫、细胞生物学和分子生物学等方面对妇科内分泌疾病的发病机制有了更深入的了解;
作者 陈子江
出处 《中华妇产科杂志》 CAS CSCD 北大核心 2010年第8期561-563,共3页 Chinese Journal of Obstetrics and Gynecology
  • 相关文献

参考文献14

  • 1Aruna M,Nagaraja T,Andal S,et al.Role of progesterone receptor polymorphisms in the recurrent spontaneous abortions:Indian case.PLoS One,2010,5:8712.
  • 2Franks S,Stark J,Hardy K.Follicle dynamics and anovulation in polycystic ovary syndrome.Hum Reprod Update,2008,14:367-378.
  • 3Durnerin CI,Erb K,Fleming R,et al.Effects of recombinant LH treatment on folliculogenesis and responsiveness to FSH stimulation.Hum Reprod,2008,23:421-426.
  • 4Broekmans FJ,Kwee J,Hendriks DJ,et al.A systematic review of tests predicting ovarian reserve and IVF outcome.Hum Reprod Update,2006,12:685-718.
  • 5尹毅,陈昌元,张生皆,高清源,叶志香.106例围绝经期妇女健康现状问卷调查资料分析[J].中国妇幼保健,2008,23(29):4175-4176. 被引量:1
  • 6Torgerson DJ,Bell-Syer SE.Hormone replacement therapy and prevention of nonvertebral fractures:a meta-analysis of randomized trials.JAMA,2001,285:2891-2897.
  • 7Torgerson DJ,Bell-Syer SE.Hormone replacement therapy and prevention of vertebral fractures:a meta-analysis of randomised trials.BMC Musculoskelet Disord,2001,2:7.
  • 8Maclaughlin EJ,Sleeper RB,McNatty D,et al.Management of age-related osteoporosis and prevention of associated fractures.Ther Clin Risk Manag,2006,2:281-295.
  • 9Cooke GM.A review of the animal models used to investigate the health benefits of soy isoflavones.J AOAC Int,2006,89:1215-1227.
  • 10多囊卵巢综合征的诊断和治疗专家共识[J].中华妇产科杂志,2008,43(7):553-555. 被引量:322

二级参考文献24

  • 1中华医学会糖尿病学分会代谢综合征研究协作组.中华医学会糖尿病学分会关于代谢综合征的建议[J].中国糖尿病杂志,2004,12(3):156-161. 被引量:3043
  • 2赵君利,陈子江,赵跃然,王来城,赵力新,唐蓉,马增香,石玉华.PAI-1基因4G/5G多态性与PCOS糖代谢、肥胖的相关性研究[J].实用妇产科杂志,2006,22(7):406-409. 被引量:4
  • 3Trivax B, Azziz R. Diagnosis of polycystic ovary syndrome. Clin Obstet Gynecol,2007, 50:168-177.
  • 4Shi Y, Guo M, Yan J, et al. Analysis of clinical characteristics in large-scale Chinese women with polycystic ovary syndrome. Neuro Endocrinol Lett ,2007,28 : 807-810.
  • 5Jafari K, Javaheri G, Ruiz G. Endometrial adenocarcinoma and the Stein-Leventhal syndrome. Obstet Gynecol,1978,51:97-100.
  • 6Kurabayashi T, Kase H, Suzuki M,et al. Endometrial abnormalities in infertile women. J Reprod Med ,2003 ,48 :455-459.
  • 7Wijeyaratne CN, Balen AH, Barth JH, et al. Clinical manifestations and insulin resistance (IR) in polycystic ovary syndrome (PCOS) among South Asians and Caucasians: Is there a difference? Clin Endocrinol,2002 ,57 :343-350.
  • 8Kelestimur F, Unluhizarci K, Baybuga H, et al. Prevalence of polycystic ovarian changes and polycystic ovary syndrome in premenopausal women with treated type 2 diabetes mellitus. Fertil Steril, 2006,86 : 405 -410.
  • 9Conn JJ, Jacobs HS, Conway GS. The prevalence of polycystic ovaries in women with type-2 diabetes mellitus. Clin Endocrinol, 2000,52:81-86.
  • 10Reaven GM. Role of insulin resistance in human disease. Diabetes, 1988,37 : 1595-1607.

共引文献595

同被引文献27

  • 1张以文.重视绝经过渡期变化的复杂性[J].国外医学(妇产科学分册),2007,34(3):153-155. 被引量:3
  • 2Committee onGynecologic Practice of American College of Obste- tricians and Gynecologists, Practice Committee of American Society for Reproductive Medicine. Age-related fertility decline : a com- mittee opinion[ J]. Fertil Steril,2008,90(5 Suppl) :$154-155.
  • 3Broekmans FJ,Soules MR, fanser BC. Ovarian aging: mecha- nisms and clinical consequences[J]. Endocr Rev,2009 ,30 :465- 493.
  • 4Panay N,Fenton A. Can we predict the age of menopause transi- tion ? [ J ] Climacteric, 201 O, 13 ( 6 ) :507 -508.
  • 5Vogel G. Where do human eggs come from? [ J ]. Stem Cells, 2011,334(6052) :27-36.
  • 6vanLoendersloot LL, Moolenaar LM, Mol BW, et al. Expanding reproductive lifespan : a cost-effectiveness Study on oocyte freezing [J]. Hum Reprod,2011,26( 11 ) :3054-3060.
  • 7Knauff EA, Eijkemans MJ, Lambalk CB, et al. Anti-Mullerian hormone, inhibin B, and antral follicle count in young women with ovarian failure [ J ]. J Clin Endocrinol Metab, 2009,94 ( 3 ) : 786-792.
  • 8Panay N, Kalu E. Management of premature ovarian failure [ J ]. Best Pract Res Clin Obstet Gynaeco1,2009,23 (1) :129-140.
  • 9Kelton PT,Michele K, Alan G, et al. Anti-Mtillerian hormone as a marker of ovarian reserve[J]. Anzjog,2005,45 (1) :202-241.
  • 10Kelton PT,Michele K, Alan G, et al. Anti-Mtillerian hormone as a marker of ovarian reserve[J]. Anzjog,2005,45 (1) :202- 241.

引证文献2

二级引证文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部